|
WO2007104160A1
|
|
Identification of biomolecules through expression patterns in mass spectrometry
|
|
WO2007089793A2
|
|
Tat-041 and methods of assessing and treating cancer
|
|
WO2007089792A2
|
|
Tat-046 and methods of assessing and treating cancer
|
|
WO2007089783A2
|
|
Tat-044 and methods of assessing and treating cancer
|
|
WO2007089690A2
|
|
Tat-042 and methods of assessing and treating cancer
|
|
WO2007087370A2
|
|
Tat-038 and methods of assessing and treating cancer
|
|
WO2007084708A2
|
|
Tat-028 and methods of assessing and treating cancer
|
|
WO2007022625A1
|
|
Peptide reversion methods and uses thereof
|
|
WO2007005559A2
|
|
Tat-005 and methods of assessing and treating cancer
|
|
WO2006133568A1
|
|
Virtual mass spectrometry
|
|
WO2006133145A2
|
|
Tat-007 and methods of assessing and treating cancer
|
|
WO2006122424A1
|
|
Protein depletion using volatile binding buffers
|
|
WO2006116681A2
|
|
Tat-003 and methods of assessing and treating cancer
|
|
WO2006116541A2
|
|
Tat-002 and methods of assessing and treating cancer
|
|
US2007106065A1
|
|
TAT- 001 and methods of assessing and treating cancer
|
|
AU2004203724A1
|
|
Glycopeptide identification and analysis
|
|
CA2503292A1
|
|
Constellation mapping and uses thereof
|
|
WO2004029072A2
|
|
PrPsc -INTERACTING MOLECULES AND USES THEREOF
|
|
EP1446667A2
|
|
Mass intensity profiling system and uses thereof
|
|
WO03025565A2
|
|
Preparation of highly-purified plasma membranes
|
